The estimated Net Worth of Joseph C Papa is at least $26.5 Milion dollars as of 10 May 2022. Mr. Papa owns over 366,130 units of Bausch Health Companies Inc stock worth over $9,322,979 and over the last 20 years he sold BHC stock worth over $0. In addition, he makes $17,141,600 as Chairman of the Board i Chief Executive Officer at Bausch Health Companies Inc.
Sign up
Mr. Papa BHC stock SEC Form 4 insiders trading
Joseph has made over 13 trades of the Bausch Health Companies Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 366,130 units of BHC stock worth $2,335,909 on 10 May 2022.
The largest trade he's ever made was exercising 366,130 units of Bausch Health Companies Inc stock on 10 May 2022 worth over $2,335,909. On average, Joseph trades about 31,189 units every 89 days since 2004. As of 10 May 2022 he still owns at least 1,461,282 units of Bausch Health Companies Inc stock.
You can see the complete history of Mr. Papa stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Joseph Papa biography
Joseph C. (Joe) Papa is Chairman of the Board, Chief Executive Officer of the Company. Mr. Papa has more than 35 years of experience in the pharmaceutical, healthcare and specialty pharmaceutical industries, including 20 years of branded prescription drug experience. He served as the CEO of Perrigo Company plc (“Perrigo”) from 2006 to April 2016, where he also served as Chairman from 2007 to April 2016. Prior to joining Perrigo, Mr. Papa served from 2004 to 2006 as Chairman and CEO of the Pharmaceutical and Technologies Services segment of Cardinal Health, Inc. From 2001 to 2004, he served as President and Chief Operating Officer of Watson Pharmaceuticals, Inc. (“Watson”). Prior to joining Watson, Mr. Papa held management positions at DuPont Pharmaceuticals, Pharmacia/Searle and Novartis AG. Mr. Papa served as a director of Smith & Nephew plc, a developer of advanced medical devices, from 2008 to April 2018.
What is the salary of Joseph Papa?
As the Chairman of the Board i Chief Executive Officer of Bausch Health Companies Inc, the total compensation of Joseph Papa at Bausch Health Companies Inc is $17,141,600. There are no executives at Bausch Health Companies Inc getting paid more.
How old is Joseph Papa?
Joseph Papa is 64, he's been the Chairman of the Board i Chief Executive Officer of Bausch Health Companies Inc since 2016. There are 7 older and 13 younger executives at Bausch Health Companies Inc. The oldest executive at Bausch Health Companies Inc is Richard De Schutter, 79, who is the Independent Director.
What's Joseph Papa's mailing address?
Joseph's mailing address filed with the SEC is C/O MILESTONE PHARMACEUTICALS INC., 1111 DR. FREDERIK-PHILIPS BLVD, STE 420, MONTREAL, A8, H4M 2X6.
Insiders trading at Bausch Health Companies Inc
Over the last 6 years, insiders at Bausch Health Companies Inc have traded over $2,786,244 worth of Bausch Health Companies Inc stock and bought 6,317,686 units worth $110,094,785 . The most active insiders traders include John Paulson, Argeris N Karabelas oraz Brett Icahn. On average, Bausch Health Companies Inc executives and independent directors trade stock every 36 days with the average trade being worth of $824,564. The most recent stock trade was executed by Seana Carson on 5 September 2024, trading 13,370 units of BHC stock currently worth $83,028.
What does Bausch Health Companies Inc do?
bausch health companies inc. (nyse/tsx: bhc) is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. we are delivering on our commitments as we build an innovative company dedicated to advancing global health. our approximately 22,000 employees are united around our mission of improving people’s lives with our health care products, and we manufacture and market health care products directly or indirectly in approximately 100 countries.five pillars, or guiding principles, represent the foundation on which we are realizing our mission as an organization: people, quality health care outcomes, customer focus, innovation and efficiency. more information can be found at www.bauschhealth.com.###
What does Bausch Health Companies Inc's logo look like?
Complete history of Mr. Papa stock trades at Cardinal Health, Emergent Biosolutions Inc, Perrigo plc, Bausch Health Companies Inc oraz Milestone Pharmaceuticals Inc
Bausch Health Companies Inc executives and stock owners
Bausch Health Companies Inc executives and other stock owners filed with the SEC include:
-
Joseph Papa,
Chairman of the Board, Chief Executive Officer -
Paul Herendeen,
Chief Financial Officer, Executive Vice President -
Joseph C. Papa,
CEO & Chairman -
Thomas Appio,
President & Co-Head Bausch + Lomb/International -
William Humphries,
-
Christina Ackermann,
Executive Vice President, General Counsel -
Thomas J. Appio,
Pres & Co-Head Bausch + Lomb/International -
Paul S. Herendeen,
Exec. VP and Advisor to Chairman & CEO -
Joseph Gordon,
President & Co-Head Bausch + Lomb/International -
Christina M. Ackermann,
Exec. VP, Gen. Counsel & Head of Commercial Operations -
Thomas Ross,
Lead Independent Director -
Russel Robertson,
Independent Director -
Robert Power,
Independent Director -
Argeris Karabelas,
Independent Director -
Sarah Kavanagh,
Independent Director -
D. Robert Hale,
Independent Director -
Amy Wechsler,
Independent Director -
Richard De Schutter,
Independent Director -
Andrew Charles von Eschenbach,
Independent Director -
John Paulson,
Independent Director -
Tom G. Vadaketh,
Chief Financial Officer -
Frederick J. Munsch,
Controller & Chief Accounting Officer -
Kelly Webber,
Sr. VP & Chief HR Officer -
Stacey Williams,
VP of Marketing -
Michael McMyne,
VP of Sales -
Arthur J. Shannon,
Sr. VP and Head of Investor Relations & Communications -
Dr. Robert F. Butz,
VP of Medical & Scientific Affairs -
Osama A. Eldessouky,
CFO & Exec. VP -
Christian A Garcia,
Director -
Frank D. Lee,
Director -
Mark C. Mc Kenna,
President, Salix -
Holdings, L.P.Value Act Hol...,
-
Brett Icahn,
Director -
Steven D Miller,
Director -
Tom George Vadaketh,
EVP, Chief Financial Officer -
Holdings, L.P.Value Act Cap...,
-
Aimee J. Lenar,
EVP, US Pharma -
Seana Carson,
EVP, General Counsel -
David Robert Value Act Hold...,
-
Sam Eldessouky,
EVP & Chief Financial Officer -
Frederick Munsch,
SVP, Controller and CAO -
Robert Spurr,
President, U.S. Businesses -
Richard Mulligan,
Director -
John S Barresi,
SVP, Controller & CAO -
Jean Jacques Charhon,
EVP, CFO